Dignify Therapeutics, LLC
About Dignify Therapeutics, LLC
Dignify Therapeutics LLC is a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions through safe, effective, practical and convenient 'on-demand' pharmaceutical agents. The company is a member of the First Flight Venture Center and is located in Research Triangle Park, NC. It has received funding from founders, NIH grants, the North Carolina Biotechnology Center, venture capital, and individual investors. Dignify was founded in 2013 by serial entrepreneurs who are internationally recognized scientists and clinicians.
- 🔗 For Investors - Dignify Therapeutics
- 🔗 Dignify Therapeutics - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 Dignify Therapeutics Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 Dignify Therapeutics Completes Preferred Equity Financing - Dignify Therapeutics
- 🔗 Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH) - Dignify Therapeutics
Key highlights
- Completed $3.15M preferred equity financing in 2015 to advance preclinical and Phase I studies.
- Received multiple NIH research grants including two new awards announced in 2024.
- Focuses on on-demand drugs for bladder and bowel voiding dysfunctions in neurological conditions.
- Backed by RA Capital Management and Eshelman Ventures among other investors and grant programs.
- Located at First Flight Venture Center with over 12 years of grant management support.
Ask StreetZero about Dignify Therapeutics, LLC
Put our AI to work on this deal.
Similar companies
Other Pharmaceuticals deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account